全球抗寄生虫药物市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

全球抗寄生虫药物市场需求预计将从 2023 年的 183 亿美元增至 2032 年近 312.9 亿美元，2024-2032 年研究期间CAGR为 6.14%。

抗寄生虫药是用来治疗寄生虫（包括原生动物、蠕虫和节肢动物）引起的感染的药物。这些药物透过杀死或抑制宿主体内寄生虫的生长来发挥作用。常见的例子包括抗疟药、驱虫药和抗原虫药。这些药物对于对抗寄生虫疾病、促进公共卫生工作和改善受影响个人的福祉至关重要。

市场动态

寄生虫感染的流行、人们对被忽视的热带疾病的认识不断提高以及药物开发的进步等因素推动了抗寄生虫药物市场的发展。疟疾、利甚曼病和蠕虫感染等寄生虫疾病的全球负担推动了对有效抗寄生虫药物的需求。专注于消除寄生虫病的政府措施和国际合作进一步促进了市场成长。发现新型抗寄生虫药物的研究和开发工作以及联合疗法的引入增强了治疗选择。市场也受到社会经济因素的影响，因为寄生虫感染对低收入地区的人口影响尤其严重。人们越来越重视「同一个健康」策略，该策略承认人类、动物和环境健康之间的相互联繫，凸显了抗寄生虫药物在全球健康倡议中的关键作用。这些药物在解决和管理超越物种界限的健康挑战方面发挥关键作用，有助于旨在改善全球整体公共卫生的综合努力。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球抗寄生虫药物市场的各个细分市场进行了包容性评估。抗寄生虫药物产业的成长和趋势为本研究提供了整体方法。

市场区隔

抗寄生虫药物市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

依疾病类型

• 爱滋病
• 肝炎
• 流感
• 结核病
• 疟疾
• HPV病毒

按最终用途

• 医院
• 诊所
• 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲抗寄生虫药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。抗寄生虫药市场的主要参与者包括诺华公司、吉利德、葛兰素史克公司、杨森製药公司、罗氏公司、BioCryst Pharmaceuticals, Inc.、默克公司、勃林格殷格翰公司有限公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：抗寄生虫药物 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按疾病类型分類的市场吸引力分析
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球抗寄生虫药物市场分析：按疾病类型

• 依疾病类型概述
• 历史和预测数据
• 依疾病类型分析
• 爱滋病
• 肝炎
• 流感
• 结核病
• 疟疾
• HPV病毒

第 6 章：全球抗寄生虫药物市场分析：依最终用途分类

• 按最终用途分類的概述
• 历史和预测数据
• 按最终用途分析
• 医院
• 诊所
• 其他的

第 7 章：全球抗寄生虫药物市场分析：按地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 8 章：抗寄生虫药物公司的竞争格局

• 抗寄生虫药市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 9 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Novartis AG.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Gilead
• 公司简介
• 公司收入
• 产品
• 最近的发展
• GlaxoSmithKline plc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Janssen Pharmaceutical Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• F. Hoffmann-La Roche Ltd.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• BioCryst Pharmaceuticals Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Merck & Co. Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Boehringer Ingelheim GmbH.
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Antiparasitic Drugs Market is presumed to reach the market size of nearly USD 31.29 Billion by 2032 from USD 18.3 Billion in 2023 with a CAGR of 6.14% under the study period 2024 - 2032.

Antiparasitic drugs are medications designed to treat infections caused by parasites, including protozoa, helminths, and arthropods. These drugs work by either killing or inhibiting the growth of parasites within the host organism. Common examples include antimalarials, anthelmintics, and antiprotozoals. These drugs are essential in combating parasitic diseases, contributing to public health efforts, and improving the well-being of affected individuals.

MARKET DYNAMICS

The Antiparasitic drugs market is propelled by factors such as the prevalence of parasitic infections, increasing awareness of neglected tropical diseases, and advancements in drug development. The global burden of parasitic diseases, including malaria, leishmaniasis, and helminth infections, drives the demand for effective antiparasitic medications. Government initiatives and international collaborations focusing on eliminating parasitic diseases further contribute to market growth. Research and development efforts to discover novel antiparasitic drugs and the introduction of combination therapies enhance treatment options. The market is also influenced by socioeconomic factors, as parasitic infections disproportionately affect populations in low-income regions. The increasing emphasis on One Health strategies, which acknowledge the interconnectedness of human, animal, and environmental health, highlights the crucial role of antiparasitic drugs in global health initiatives. These medications play a pivotal role in addressing and managing health challenges that transcend species boundaries, contributing to comprehensive efforts aimed at improving overall public health on a global scale.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of antiparasitic drugs. The growth and trends of antiparasitic drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the antiparasitic drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease Type

• HIV
• Hepatitis
• By Influenza
• TB
• Malaria
• HPV

By End Use

• Hospitals
• Clinics
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Antiparasitic Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antiparasitic Drugs market include Novartis AG., Gilead, GlaxoSmithKline plc., Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals, Inc., Merck & Co., Inc., Boehringer Ingelheim GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ANTIPARASITIC DRUGS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Disease Type
  • 3.7.2 Market Attractiveness Analysis By End Use
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ANTIPARASITIC DRUGS MARKET ANALYSIS BY DISEASE TYPE

• 5.1 Overview by Disease Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Disease Type
• 5.4 HIV Historic and Forecast Sales by Regions
• 5.5 Hepatitis Historic and Forecast Sales by Regions
• 5.6 Influenza Historic and Forecast Sales by Regions
• 5.7 TB Historic and Forecast Sales by Regions
• 5.8 Malaria Historic and Forecast Sales by Regions
• 5.9 HPV Historic and Forecast Sales by Regions

6 . GLOBAL ANTIPARASITIC DRUGS MARKET ANALYSIS BY END USE

• 6.1 Overview by End Use
• 6.2 Historical and Forecast Data
• 6.3 Analysis by End Use
• 6.4 Hospitals Historic and Forecast Sales by Regions
• 6.5 Clinics Historic and Forecast Sales by Regions
• 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL ANTIPARASITIC DRUGS MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. South East Asia Sales Analysis
  • 7.5.10. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE ANTIPARASITIC DRUGS COMPANIES

• 8.1. Antiparasitic Drugs Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF ANTIPARASITIC DRUGS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Novartis AG.
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Gilead
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. GlaxoSmithKline plc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Janssen Pharmaceutical Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. F. Hoffmann-La Roche Ltd.
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. BioCryst Pharmaceuticals Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Merck & Co. Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Boehringer Ingelheim GmbH.
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Disease Type (USD MN)
• HIV Market Sales by Geography (USD MN)
• Hepatitis Market Sales by Geography (USD MN)
• Influenza Market Sales by Geography (USD MN)
• TB Market Sales by Geography (USD MN)
• Malaria Market Sales by Geography (USD MN)
• HPV Market Sales by Geography (USD MN)
• Analysis Market by End Use (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Clinics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Antiparasitic Drugs Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Antiparasitic Drugs Report
• Market Research Process
• Market Research Methodology
• Global Antiparasitic Drugs Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Disease Type
• Market Attractiveness Analysis by End Use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Disease Type (USD MN)
• HIV Market Sales by Geography (USD MN)
• Hepatitis Market Sales by Geography (USD MN)
• Influenza Market Sales by Geography (USD MN)
• TB Market Sales by Geography (USD MN)
• Malaria Market Sales by Geography (USD MN)
• HPV Market Sales by Geography (USD MN)
• Global Market Analysis by End Use (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Clinics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.